engcon AB (publ) (FRA:917)

Market Cap	1.05B
Revenue (ttm)	159.48M
Net Income (ttm)	20.98M
Shares Out	n/a
EPS (ttm)	0.14
PE Ratio	49.94
Forward PE	36.83
Dividend	0.09 (1.33%)
Ex-Dividend Date	May 16, 2025

Volume	n/a
Average Volume	174
Open	6.75
Previous Close	6.89
Day's Range	6.75 - 6.75
52-Week Range	6.57 - 10.68
Beta	n/a
RSI	33.59
Earnings Date	Jul 18, 2025

About Intra-Cellular Therapies

engcon AB (publ) engages in the design, production, and sale of excavator tools in Sweden, Denmark, Norway, Finland, rest of Europe, North and South America, Japan, South Korea, Australia, New Zealand, and internationally. The company offers control systems; track and wheel control products; DC2, a proportional control system with remote support; track and wheel control; MIG2, an integrated hand support joystick; EC-Oil, an automatic hydraulic connector; positioning systems; locking systems; Q-Safe Light Module, a control system of warning ligh...

• Industry: Construction, Mining, And Materials Handling
• Founded: 1990
• Employees: 400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 917

Financial Performance

In 2024, engcon AB's revenue was 1.65 billion, a decrease of -13.12% compared to the previous year's 1.90 billion. Earnings were 216.00 million, a decrease of -21.45%.